P17.50PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS
Article
Kumthekar, P, Grimm, SA, Marymont, M et al. (2014). P17.50PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS
. NEURO-ONCOLOGY, 16(suppl_2), ii99-ii99. 10.1093/neuonc/nou174.379
Kumthekar, P, Grimm, SA, Marymont, M et al. (2014). P17.50PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS
. NEURO-ONCOLOGY, 16(suppl_2), ii99-ii99. 10.1093/neuonc/nou174.379